Skip to main navigation
  • HOME
  • ABOUT ENZON
  • ROYALTY PRODUCTS
  • INVESTORS & MEDIA

    Investor Relations

    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Stock Quote
    • Stock Lookup
    • Contact Us
  • CONTACT US
  • Request Information
  • Email Alerts
  • Download Library
  • RSS News Feeds
Shareholder Tools
Downloads
Print

Downloads

Apr 13, 2009
2009 Proxy Statement 485.5 KB
Apr 13, 2009
2009 Proxy Card 39.8 KB
Mar 19, 2009
Enzon Reveals New LNA Targets 12.4 KB
Mar 19, 2009
Enzon Treats Patients with Survivin Antagonist 10.1 KB
Mar 16, 2009
Enzon to Present at 29th Annual Cowen and Company Healthcare Conference 7.7 KB
Feb 19, 2009
Enzon Reports 2008 Results 36 KB
Feb 13, 2009
Enzon to Release Fourth Quarter 2008 Earnings on Thursday, February 19, 2009; Conference Call and Webcast to Follow 9.8 KB
Feb 10, 2009
Enzon Discontinues Further Development of rhMBL 10 KB
Feb 10, 2009
Enzon Announces IND Acceptance for Its Survivin Antagonist 10.5 KB
Feb 04, 2009
Enzon to Present at 11th Annual BIO CEO & Investor Conference 7.8 KB

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Current page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • …
  • Next page next ›
  • Last page last »

©2025 Enzon Pharmaceuticals, Inc., All Rights Reserved.